Cortechs.ai | Are you achieving reliable and accurate results when using NeuroQuant<sup>®</sup>?

Are you achieving reliable and accurate results when using NeuroQuant®?

Cortechs.ai | Are you achieving reliable and accurate results when using NeuroQuant<sup>®</sup>?Since MRI acquisition protocols used can have an impact on the reliability and accuracy of NeuroQuant’s MR image segmentation and volume measurements, the engineering and support teams at Cortechs.ai have put together a lot of great and pertinent information to help ensure our customers achieve the best possible outcomes when using Cortechs.ai products.

To optimize results, we advise the following:

1. Use the recommended scanner settings for each MRI manufacturers and models. Find them here.

2. Review the Frequently Asked Questions. Read those here.

3. Read the following blog posts:

To help make de-identifying data easy and painless, Cortechs.ai added a feature to CTXNode (our secure cloud processing system) allowing MRI scan data can be easily de-identified during the process of uploading to NeuroQuant. Read post.

Contrast agents are typically used to study vasculature, something that is not needed for volumetric MR imaging. NeuroQuant requires a non-contrasted, 3D T1 sagittal sequence to segment and measure brain structure volumes. Read post.

Alignment to atlas is an important step in NeuroQuant’s analysis process. To achieve its high quality segmentation results, NeuroQuant aligns each patient’s brain image to an atlas of the brain. Read post.

Patients who have shunts, implants or other artifacts or inherent abnormalities, can potentially generate segmentation misregistration. To prevent such errors and protect the accuracy of the results, NeuroQuant prevents analysis when such artifacts or anatomical anomalies are present. Read post.

3D T1 sagittal MRIs are needed to obtain ideal brain morphometry for volume analysis. In order to achieve its high quality segmentation results, NeuroQuant has been optimized for processing 3D T1 sagittal MRI acquisition sequence in 1.5 and 3.0T closed scanners. Read post.

If a sequence is acquired and uploaded to NeuroQuant with any of the X, Y or Z coordinates outside +/-100mm, automated volumetric analysis cannot be performed. An NeuroQuant error message will be returned. Read post.

4. Consult the NeuroQuant User Manual.

5. Contact the support team with any questions.

Cortechs.ai | Are you achieving reliable and accurate results when using NeuroQuant<sup>®</sup>?

More Resources

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.
Scroll to Top